- https://www.novartis.com/stories/women-science-annie-martin
Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.
- https://www.novartis.com/stories/women-science-mimi-huizinga
Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
- https://www.novartis.com/stories/women-science-hannah-mosca
Oncology Regulatory Affairs Leader Hannah Mosca describes her lifelong interest in science and math, and what it’s like to work at Novartis
- https://www.novartis.com/stories/women-science-lauren-abrey
Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.
- https://www.novartis.com/stories/building-collaborations-fight-pandemic
Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.
- https://www.novartis.com/stories/intractable-tumor-cells-crippled
Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.
- https://www.novartis.com/stories/keeping-heart-patients-heart-everything-we-do
For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.
- https://www.novartis.com/stories/let-there-be-sight
- https://www.novartis.com/stories/loss-friend-liver-cancer-sharpens-focus-experimental-therapy
A Novartis experimental drug in clinical trial aims to block liver cancer growth
- https://www.novartis.com/stories/killing-three-diseases-one-stone-lab
Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.
Pagination
- ‹ Previous page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- …
- 38
- › Next page